Myriad Genetics, Inc. (LON:0K3W)
London · Delayed Price · Currency is GBP · Price in USD 3.935
-0.255 (-6.09%)
At close: Jul 31, 2025
Verve Therapeutics Market Cap
Myriad Genetics has a market cap or net worth of 272.09 million as of August 1, 2025. Its market cap has decreased by -85.57% in one year.
Market Cap
272.09M
Enterprise Value
321.77M
Revenue
643.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.94
Market Cap Chart
Since October 6, 1995, Myriad Genetics's market cap has increased from 110.60M to 272.09M, an increase of 146.01%. That is a compound annual growth rate of 3.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 272.09M | -72.71% |
| Dec 31, 2024 | 996.94M | -25.18% |
| Dec 29, 2023 | 1.33B | 36.53% |
| Dec 30, 2022 | 975.86M | -40.05% |
| Dec 31, 2021 | 1.63B | 49.42% |
| Dec 31, 2020 | 1.09B | -28.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 178.30B |
| GSK plc | 59.04B |
| Haleon | 32.79B |
| Smith & Nephew | 10.33B |
| ConvaTec Group | 5.00B |
| Hikma Pharmaceuticals | 4.40B |
| HUTCHMED (China) | 2.34B |
| Oxford Nanopore Technologies | 1.94B |